Drug patents opposed in 2020
Drug patents opposed in 2020 at the European Patent Office (EPO)
| Patent Number | Patent Title | Company | Recent Opposition Date | Recent Opposition By | Activity Alert |
|---|---|---|---|---|---|
| EP3236939B1 | Botulinum Toxin Prefilled Container | MERZ PHARMA |
31 Dec, 2020
|
ALLERGAN
| |
| EP3470059B1 | Ophthalmic Suspension Composition | BAUSCH & LOMB INCORPORATED |
30 Dec, 2020
|
SANDOZ
| |
| EP3136861B1 | Composition Containing Peroxide And An Antimicrobial Agent And Process Of Killing Spores | AMERICAN STERILIZER CO |
29 Dec, 2020
(Expiration: Feb, 2035)
|
BODE CHEMIE
| |
| EP2309876B1 | Nutritional Composition Containing Oligosaccharide Mixture | SOCIT DES PRODUITS NESTL |
24 Dec, 2020
|
NUTRICIA
(and 1 more)
| |
| EP3383366B1 | Pharmaceutical Composition | MEXICHEM FLUOR DE CV |
23 Dec, 2020
|
BECK GREENER
| |
| EP3041581B1 | Hair Care Composition Comprising Amino Silicone, Fatty Alcohol And Paraffin Oil | ALVES DIEGO M |
23 Dec, 2020
(Expiration: Sep, 2033)
|
HENKEL
| |
| EP3191081B1 | Formulation Comprising Glycopyrrolate, Method And Apparatus | VECTURA |
22 Dec, 2020
|
BECK GREENER
| |
| EP3268337B1 | Methods And Kits For Preparing Radionuclide Complexes | THERAGNOSTICS |
22 Dec, 2020
|
DEHMEL & BETTENHAUSEN PATENTANWLTE PARTMBB
| |
| EP3423028B1 | Method For The Production Of Scent Capsules With Improved Surfactant Stablity | SYMRISE AG |
22 Dec, 2020
(Expiration: Feb, 2036)
|
VO
(and 1 more)
| |
| EP2395983B1 | Pharmaceutical Composition Comprising A Sglt2 Inhibitor, A Dpp-Iv Inhibitor And Optionally A Further Antidiabetic Agent And Uses Thereof | BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
22 Dec, 2020
(Expiration: Feb, 2030)
|
ZAKLADY FARMACEUTYCZNE POLPHARMA
(and 2 more)
| |
| EP3043797B1 | Treating Infections With Ceftolozane/Tazobactam In Subjects Having Impaired Renal Function | MERCK SHARP & DOHME |
21 Dec, 2020
|
LEDERER & KELLER PATENTANWLTE PARTNERSCHAFT MBB
| |
| EP3199164B1 | Processes For Making Lactose Utilizing Pre-Classification Techniques And Pharmaceutical Formulations Formed Therefrom | GLAXO GROUP |
18 Dec, 2020
|
ADAMSON JONES
| |
| EP2928454B1 | New Treatments With Triazines | CEVA SANT ANIMALE |
18 Dec, 2020
|
ELANCO
(and 1 more)
| |
| EP3389604B1 | Composition Comprising A Combination Of Particular Alkoxysilanes And A Fatty Substance | LOREAL |
18 Dec, 2020
|
HENKEL
| |
| EP3412687B1 | Methods For Treating Dlbcl | AMGEN RESEARCH MUNICH |
18 Dec, 2020
|
JAMES POOLE
| |
| EP3102187B1 | Stable Pharmaceutical Compositions Containing Sitagliptin In The Form Of Immediate Release Tablets | GALENICUM HEALTH SLU |
17 Dec, 2020
|
ELKINGTON AND FIFE
(and 6 more)
| |
| EP3437627B1 | 2-Propylheptylocanoat In Cosmetic Preparations | BEIERSDORF |
17 Dec, 2020
|
LOREAL
| |
| EP2094246B1 | Sustained-Release Composition And Method For Producing The Same | TAKEDA PHARMACEUTICAL |
16 Dec, 2020
|
INSTONE TERRY READ HOWARD GRAHAM APPLEYARD LEES
| |
| EP2545777B2 | Isoxazoline Compositions And Their Use As Antiparasitics | INTERVET |
11 Dec, 2020
|
CEVA SANTE ANIMALE
(and 1 more)
| |
| EP2139494B1 | Pharmaceutical Formulations Containing Dapagliflozin Propylene Glycol Hydrate | ASTRAZENECA |
11 Dec, 2020
(Expiration: Mar, 2028)
|
KRAUS & WEISERT PATENTANWLTE PARTGMBB
(and 5 more)
| |
| EP2708147B1 | Methods For Increasing Brain Functionality Using 2-Fucosyl-Lactose | ABBOTT LABORATORIES |
11 Dec, 2020
(Expiration: Sep, 2032)
|
NUTRICIA
(and 2 more)
| |
| EP2802333B1 | Lactobacillus Rhamnosus And Bifidobacterium Animalis Subsp. Lactis For Use In Prevention Or Treatment Of Upper Respiratory Tract Infections | CHR HANSEN |
10 Dec, 2020
|
DUPONT NUTRITION BIOSCIENCES APS
| |
| EP3087098B1 | Anti-Vista Antibodies And Fragments | JANSSEN PHARMACEUTICA NV |
10 Dec, 2020
(Expiration: Dec, 2034)
|
MARGARET DIXON
(and 1 more)
| |
| EP3395338B1 | Rapid Dissolution Formulation Of Cinacalcet Hcl | AMGEN INC |
09 Dec, 2020
(Expiration: Sep, 2024)
|
BETAPHARM ARZNEIMITTEL
(and 6 more)
| |
| EP3562467B2 | An Antimicrobial Composition | UNILEVER |
07 Dec, 2020
|
HENKEL
| |
| EP2978446B1 | Methods And Agents For Treating Alzheimer'S Disease | GENERAL HOSPITAL CORP |
04 Dec, 2020
(Expiration: Mar, 2034)
|
ABBVIE
(and 2 more)
| |
| EP3126373B1 | Method For Preparing Amg 416 | AMGEN |
04 Dec, 2020
|
COPA COPENHAGEN PATENTS KS
| |
| EP3453378B1 | A Cosmetic Gel Composition | SOCIET ITALO BRITANNICA L MANETTI H ROBERTS & CPA |
04 Dec, 2020
|
HENKEL
| |
| EP3231805B1 | Salt Of Pyrrolo[2,3-D]Pyrimidine Compound And Novel Polymorph Of Salt | CRYSTAL PHARMATECH CO LTD |
04 Dec, 2020
(Expiration: Dec, 2035)
|
SAGITTARIUS CONSULTANTS
| |
| EP3492109B1 | Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof | MODERNATX INC |
04 Dec, 2020
(Expiration: Oct, 2032)
|
SANOFI
(and 1 more)
| |
| EP3326620B1 | Solid Compositions Comprising A Glp-1 Agonist And A Salt Of N-(8-(2- Hydroxybenzoyl)Amino)Caprylic Acid | NOVO NORDISK AS |
03 Dec, 2020
(Expiration: Dec, 2031)
|
HEXAL
(and 3 more)
| |
| EP3280416B1 | Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone Esters | JANSSEN PHARMACEUTICALS INC |
01 Dec, 2020
(Expiration: Mar, 2036)
|
INSTONE
(and 7 more)
| |
| EP3219324B1 | Application Of Dipeptide As Ace Enzyme Activity Inhibitor | WITHYOU BIOTECHNOLOGY CO LTD |
26 Nov, 2020
(Expiration: Aug, 2034)
|
DANNER
| |
| EP3338794B1 | Toxicity Management For Anti-Tumor Activity Of Cars | CHILDRENS HOSPITAL OF PHILADELPHIA CHOP |
25 Nov, 2020
(Expiration: Jul, 2033)
|
HOFFMAN EITLE PATENT UND RECHTSANWLTE PARTNERSCHAFTSGESELLSCHAFT MBB
(and 6 more)
| |
| EP2207597B1 | Light Inhibitors For Asthma, Lung And Airway Inflammation, Respiratory, Interstitial, Pulmonary And Fibrotic Disease Treatment | LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY |
19 Nov, 2020
(Expiration: Sep, 2028)
|
EUROPEAN OPPOSITIONS
| |
| EP3398446B1 | Bifidobacterium Longum And Hippocampal Bdnf Expression | SOCIETE DES PRODUITS NESTLE SA |
18 Nov, 2020
(Expiration: Apr, 2029)
|
MORINAGA MILK INDUSTRY
| |
| EP3319622B1 | Method For Producing Rna Molecule Compositions | CUREVAC AG |
12 Nov, 2020
(Expiration: Dec, 2036)
|
BIONTECH RNA PHARMACEUTICALS
| |
| EP3188713B2 | Method Of Inducing Satiety | PERORA |
12 Nov, 2020
|
DSM NUTRITIONAL PRODUCTS
| |
| EP2675423B1 | Pigment Mixtures For Cosmetics | BASF |
12 Nov, 2020
|
ECKART
| |
| EP3236918B2 | Use Of A Fatty Acid Ester For Mattifying The Skin And Composition Comprising This Ester | LOREAL |
12 Nov, 2020
|
HENKEL
| |
| EP2752488B1 | Antisense Design | ROCHE INNOVATION CENTER COPENHAGEN AS |
12 Nov, 2020
(Expiration: Nov, 2023)
|
IONIS PHARMACEUTICALS
| |
| EP3023788B1 | Compositions Of Tumor Specific Neoantigens | THE GENERAL HOSPITAL |
12 Nov, 2020
|
JAMES POOLE
| |
| EP3512603B1 | Compressed Hair Spray | UNILEVER |
12 Nov, 2020
|
LOREAL
| |
| EP3104844B1 | Complexes Of Sirolimus And Its Derivatives, Process For The Preparation Thereof And Pharmaceutical Compositions Containing Them | DRUGGABILITY TECHNOLOGIES IP HOLDCO LTD |
11 Nov, 2020
(Expiration: Feb, 2035)
|
ALKERMES PHARMA IRELAND
| |
| EP2328634B1 | Infusion Systems Including Computer-Facilitated Maintenance And/Or Operation | BRACCO DIAGNOSTICS |
11 Nov, 2020
|
JUBILANT DRAXIMAGE
| |
| EP3003284B1 | Pharmaceutical Formulations Of A Hif Hydroxylase Inhibitor | FIBROGEN |
11 Nov, 2020
|
TEVA PHARMACEUTICAL INDUSTRIES
(and 1 more)
| |
| EP2986157B1 | Fermented Nutritional Composition With Thiol Protease Inhibitor | NUTRICIA |
05 Nov, 2020
|
SOCIT DES PRODUITS NESTL
| |
| EP3077058B1 | Composition Comprising At Least One Anionic Associative Polymer, At Least One Anionic Fixing Polymer And At Least One Cationic Fixing Polymer | LORAL |
03 Nov, 2020
|
HENKEL
| |
| EP3366352B1 | Waterproof, Sprayable Sun Protection Agent | BEIERSDORF |
29 Oct, 2020
|
STADA ARZNEIMITTEL
| |
| EP3258951B1 | Anti-Pvrig Antibodies And Methods Of Use | COMPUGEN |
29 Oct, 2020
|
WITEK
(and 1 more)
| |
| EP3344289B1 | Pestivirus Vaccines For Congenital Tremors | BOEHRINGER INGELHEIM VETMEDICA GMBH |
28 Oct, 2020
(Expiration: Aug, 2036)
|
INTERVET
| |
| EP3227454B1 | Process For Manipulating The Level Of Glycan Content Of A Glycoprotein | AMGEN |
28 Oct, 2020
|
MAIWALD PATENT UND RECHTSANWALTSGESELLSCHAFT
(and 4 more)
| |
| EP3173129B1 | Sunscreen Comprising Titanium Dioxide And Ethylhexyl Salicylate | BEIERSDORF AG |
27 Oct, 2020
(Expiration: Nov, 2036)
|
DSM NUTRITIONAL PRODUCTS
(and 3 more)
| |
| EP3131912B1 | Process For Efficient Purification Of Neutral Human Milk Oligosaccharides (Hmos) From Microbial Fermentation | CHR HANSEN HMO |
22 Oct, 2020
|
BASF
(and 5 more)
| |
| EP2785702B1 | Crystalline Dapagliflozin Hydrate | SANDOZ |
22 Oct, 2020
|
GENERICS UK TRADING MYLAN
| |
| EP2258355B1 | Patch | HISAMITSU PHARMACEUTICAL |
21 Oct, 2020
|
LTS LOHMANN THERAPIE SYSTEME
| |
| EP2790681B9 | Polymer Protein Microparticles | REGENERON PHARMACEUTICALS |
21 Oct, 2020
|
WITHERS & ROGERS
| |
| EP3275871B1 | Crystals | NIPPON SHINYAKU |
15 Oct, 2020
|
GENERICS UK
| |
| EP3076996B1 | Vaccine Against Porcine Circo Virus Type 2 | INTERVET |
14 Oct, 2020
|
ELANCO
(and 1 more)
| |
| EP2919761B1 | Solid Dosage Form Comprising Micronized Cytisine | AFLOFARM FARMACJA POLSKA SP Z OO |
14 Oct, 2020
|
REDDIE & GROSE
| |
| EP2957552B1 | Vilanterol Formulations | ARVEN ILAC SANAYI VE TICARET AS |
13 Oct, 2020
(Expiration: Jun, 2035)
|
GILL JENNINGS & EVERY
(and 2 more)
| |
| EP2957551B1 | Dry Powder Formulations Comprising Vilanterol | ARVEN ILAC SANAYI VE TICARET AS |
12 Oct, 2020
(Expiration: Jun, 2035)
|
GILL JENNINGS & EVERY
(and 3 more)
| |
| EP3150586B1 | Modulators Of Pharmacokinetic Properties Of Therapeutics | GILEAD SCIENCES |
08 Oct, 2020
|
COOKE
(and 2 more)
| |
| EP2640371B1 | Vasoprotective And Cardioprotective Antidiabetic Therapy | BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
08 Oct, 2020
(Expiration: Nov, 2031)
|
GALENICUM HEALTH SLU
(and 1 more)
| |
| EP3307393B1 | Fragrance Composition | PROCTER AND GAMBLE CO |
08 Oct, 2020
(Expiration: Jun, 2036)
|
HENKEL
| |
| EP2359815B1 | Compositions Comprising Amlodipine And Bisoprolol | EGIS GYGYSZERGYR ZRT |
08 Oct, 2020
|
KRKA
| |
| EP2197287B1 | Use Of A Bifidobacterium Strain For Preparing A Composition For Preventing And/Or Treating Allergic Manifestations | COMPAGNIE GERVAIS DANONE |
08 Oct, 2020
|
SOCIT DES PRODUITS NESTL
| |
| EP3127427B1 | Methods Of Administration Of Thrombopoietin Agonist Compounds | NOVARTIS AG |
08 Oct, 2020
(Expiration: May, 2030)
|
ZENTIVA KS
(and 1 more)
| |
| EP2921155B1 | High-Quality Lipids And Methods For Producing By Enzymatic Liberation From Biomass | DSM ASSETS |
07 Oct, 2020
|
ELKINGTON AND FIFE
| |
| EP2985018B1 | Anti-Discoloration Composition | SENSIENT COSMETIC |
07 Oct, 2020
|
GARCA
| |
| EP3258919B2 | Nasal Powder Formulation For Treatment Of Hypoglycemia | ELI LILLY |
05 Oct, 2020
|
ELKINGTON AND FIFE
| |
| EP3354276B1 | Compositions For The Treatment Of Gastrointestinal Inflammation | MERITAGE PHARMA INC |
01 Oct, 2020
(Expiration: Nov, 2028)
|
AECHTER
(and 1 more)
| |
| EP3215173B8 | Glycopeptide Compositions | XELLIA PHARMACEUTICALS APS |
01 Oct, 2020
(Expiration: Nov, 2035)
|
DF MP DRRIES FRANK MOLNIA & POHLMAN
| |
| EP3071040B2 | Method For Scalable Skeletal Muscle Lineage Specification And Cultivation | THE CURATORS OF THE UNIVERSITY OF MISSOURI |
01 Oct, 2020
|
GLEISS GROE SCHRELL UND PARTNER MBB
| |
| EP3103463B1 | Adherent Cells From Adipose Or Placenta Tissues And Use Thereof In Therapy | PLURISTEM |
01 Oct, 2020
|
ICOSA EUROPE
(and 1 more)
| |
| EP3294279B1 | Compositions Comprising Amino Acids For Use In The Treatment Of Mucositides In Neoplasia Patients Undergoing Radiation Therapy And/Or Chemotherapy | PROFESSIONAL DIETETICS |
01 Oct, 2020
|
NUTRICIA
| |
| EP3431105B1 | Medicinal Composition For Treating Cancer | SHIONOGI |
30 Sep, 2020
|
GLAXOSMITHKLINE
(and 4 more)
| |
| EP3166628B2 | Therapeutic Use Of Bone Morphogenetic Proteins | CAMBRIDGE ENTERPRISE |
30 Sep, 2020
|
JAMES POOLE
| |
| EP2674147B1 | Hyaluronic Acid-Based Gels Including Anesthetic Agents | ALLERGAN INDUSTRIE SAS |
30 Sep, 2020
(Expiration: Mar, 2029)
|
MERZ PHARMA
(and 1 more)
| |
| EP2756004B1 | Methods For Reducing Lipoprotein(A) Levels By Administering An Inhibitor Of Proprotein Convertase Subtilisin Kexin-9 (Pcsk9) | REGENERON PHARMACEUTICALS |
25 Sep, 2020
|
BOEHMERT & BOEHMERT ANWALTSPARTNERSCHAFT MBB
(and 1 more)
| |
| EP3373901B1 | Dentifrice Compositions With Improved Fluoride Uptake | THE PROCTER & GAMBLE |
25 Sep, 2020
|
COLGATE PALMOLIVE
| |
| EP3173130B1 | Sunscreen Comprising Titanium Dioxide And Octocrylene | BEIERSDORF AG |
25 Sep, 2020
(Expiration: Nov, 2036)
|
DSM NUTRITIONAL PRODUCTS
(and 3 more)
| |
| EP2773748B1 | Midbrain Dopamine (Da) Neurons For Engraftment | MEMORIAL SLOAN KETTERING CANCER CENTER |
25 Sep, 2020
|
HOFFMAN EITLE PATENT UND RECHTSANWLTE PARTNERSCHAFTSGESELLSCHAFT MBB
| |
| EP3220751B1 | Complexes Of Whey Protein Micelles And Pectin And Body Muscle Protein Synthesis | SOCIT DES PRODUITS NESTL |
25 Sep, 2020
|
NUTRICIA
| |
| EP3134432B1 | Mnd Promoter Chimeric Antigen Receptors | SEVENTY BIO |
25 Sep, 2020
|
PATENT BOUTIQUE
| |
| EP3124046B1 | Combination Therapies Employing Gitr Binding Molecules | GITR |
25 Sep, 2020
|
SANOFI
| |
| EP3054784B2 | Composition And Fodder Comprising Medium Chain Fatty Acids | NUTRITION SCIENCES |
24 Sep, 2020
|
NUTRECO ASSETS
| |
| EP3189073B1 | Trophoblast Glycoprotein (5T4, Tpbg) Specific Chimeric Antigen Receptors For Cancer Immunotherapy | CELLECTIS |
24 Sep, 2020
|
OXFORD BIOMEDICA UK
| |
| EP3030249B1 | Antibodies, Compounds And Derivatives Thereof For Use In The Treatment Of Male Infertility | FERTILITYPRO APS |
24 Sep, 2020
|
PATENTANWLTE ISENBRUCK BSL HRSCHLER PARTG MBB
| |
| EP2683245B2 | Methods And Compositions For Treating Depression Using Cyclobenzaprine | TONIX PHARMA |
23 Sep, 2020
|
HEXAL
| |
| EP2535044B1 | Enterically Coated Cysteamine, Cystamine And Derivatives Thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
18 Sep, 2020
|
ALFRED E TIEFENBACHER
| |
| EP2869844B2 | Treatment For Bone Diseases | UCB PHARMA |
18 Sep, 2020
|
JAMES POOLE
| |
| EP2827835B2 | Superabsorbent Polymers And Silicone Elastomer For Use In Skin Care Compositions | THE PROCTER & GAMBLE |
18 Sep, 2020
|
LORAL
(and 1 more)
| |
| EP3388070B1 | Extensional Viscosity To Promote Safe Swallowing Of Food Boluses | SOCIETE DES PRODUITS NESTLE SA |
18 Sep, 2020
(Expiration: Mar, 2032)
|
NUTRICIA
(and 1 more)
| |
| EP2903638B1 | Immunogenic Composition | GLAXOSMITHKLINE BIOLOGICALS SA |
18 Sep, 2020
(Expiration: Oct, 2033)
|
PFIZER
| |
| EP2100902B1 | Methods For Treating Pain By Administering An Antagonist Antibody Against The Nerve Growth Factor And An Opioid Analgesic, And Compositions Containing The Same | RINAT NEUROSCIENCE |
18 Sep, 2020
|
REGENERON PHARMACEUTICALS
| |
| EP3294285B1 | Cabazitaxel And Its Use For Treating Cancer | SANOFI MATURE IP |
18 Sep, 2020
(Expiration: May, 2036)
|
ZENTIVA
(and 8 more)
| |
| EP2709672B1 | Compositions And Methods For Treating Retinal Diseases | UNIVERSITY OF CALIFORNIA |
17 Sep, 2020
(Expiration: May, 2032)
|
RENEURON
| |
| EP3331534B1 | Nutritional Compositions With 2Fl And Lnnt For Use In Inducing A Gut Microbiota Close To The One Of Breast Fed Infants | SOCIT DES PRODUITS NESTL |
16 Sep, 2020
|
RECKITT BENCKISER HEALTH
(and 3 more)
| |
| EP3127551B1 | Use Of A Pcv2 Immunogenic Composition For Lessening Clinical Symptoms In Pigs | BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC |
15 Sep, 2020
(Expiration: Dec, 2026)
|
LABORATORIOS HIPRA
(and 2 more)
| |
| EP3075744B1 | Improved Recombinant Human Follicle-Stimulating Hormone | GLYCOTOPE GMBH |
11 Sep, 2020
(Expiration: Aug, 2031)
|
AUGUST DEBOUZY
| |
| EP3214095B1 | Compositions And Methods For Modulating Immune Responses | ZYMOGENETICS |
11 Sep, 2020
|
F HOFFMANN LA ROCHE
(and 2 more)
| |
| EP2228064B1 | Pharmaceutical Composition Containing Glycopyrrolate And A Beta2 Adrenoceptor Agonist | NOVARTIS PHARMA GMBH |
11 Sep, 2020
(Expiration: May, 2025)
|
ORION ORION PHARMA
(and 9 more)
| |
| EP2410942B1 | Curable Zirconia Adhesive Compositions For Dental Restorations | BISCO INC |
11 Sep, 2020
(Expiration: Mar, 2029)
|
RIECK
| |
| EP2350096B1 | Methods Of Treating Hepatic Encephalopathy | SALIX PHARMACEUTICALS |
11 Sep, 2020
|
STADA ARZNEIMITTEL
(and 7 more)
| |
| EP3088512B1 | Use Of Placental Stem Cells For Treating Heart And Circulatory Diseases By Promoting Angiogenesis | CELULARITY INC |
10 Sep, 2020
(Expiration: Apr, 2031)
|
D YOUNG
| |
| EP2968992B8 | Eutectic Formulations Of Cyclobenzaprine Hydrochloride And Amitriptyline Hydrochloride | TONIX PHARMA |
10 Sep, 2020
|
HEXAL
| |
| EP3148521B1 | Fluticasone Furoate In The Treatment Of Copd | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LTD |
08 Sep, 2020
(Expiration: May, 2035)
|
TEVA UK
(and 1 more)
| |
| EP2763935B2 | Apparatus And Method For Generating Nitric Oxide In Controlled And Accurate Amounts | NITRICGEN |
04 Sep, 2020
|
BOCK
| |
| EP3179980B1 | Shampoo Composition | UNILEVER |
04 Sep, 2020
|
LORAL
| |
| EP3218065B1 | Compositions And Methods For The Colouring Keratinic Fibres | HENKEL AG AND CO KGAA |
04 Sep, 2020
(Expiration: Oct, 2035)
|
LOREAL
| |
| EP3058942B2 | Compositions Comprising Unsaturated Fatty Acids And Nitric Oxide Releasing Compounds And Use Thereof For Enhancing Cognitive And Related Functions | SOCIT DES PRODUITS NESTL |
04 Sep, 2020
|
MARS
(and 1 more)
| |
| EP3054993B1 | Permanent Gene Correction By Means Of Nucleotide-Modified Messenger Rna | HELMHOLTZ ZENTRUM FUR INFEKTIONSFORSCHUNG FUR DAS HELMHOLTZ INST FUR PHARMAZEUTISCHE FORSCHU GMBH |
03 Sep, 2020
(Expiration: Oct, 2034)
|
WUESTHOFF & WUESTHOFF PATENTANWLTE PARTG MBB
| |
| EP2953487B1 | Method To Convert Insects Or Worms Into Nutrient Streams And Compositions Obtained Thereby | BHLER |
03 Sep, 2020
|
YNSECT
| |
| EP3206666B1 | Liquid Pharmaceutical Composition Comprising Pemetrexed | SYNTHON |
02 Sep, 2020
|
LARSEN & BIRKEHOLM
| |
| EP3335708B1 | Administration Of Gamma Hydroxybutyrate With Monocarboxylate Transporters | JAZZ PHARMACEUTICALS IRELAND |
02 Sep, 2020
|
ZENTIVA
(and 3 more)
| |
| EP3285725B1 | Concentrated Personal Cleansing Compositions | THE PROCTER & GAMBLE |
01 Sep, 2020
|
BEIERSDORF
(and 1 more)
| |
| EP2695609B1 | Oral Formulations Of Cytidine Analogs And Methods Of Use Thereof | CELGENE |
30 Aug, 2020
|
GENERICS UK
(and 3 more)
| |
| EP3416627B9 | Oral Dosage Form Comprising Rifaximin In Form Beta | SANDOZ |
27 Aug, 2020
|
ALFASIGMA
| |
| EP2978451B1 | Compositions And Methods For Increasing The Serum Half-Life Of A Therapeutic Agent Targeting Complement C5 | ALEXION PHARMACEUTICALS INC |
27 Aug, 2020
(Expiration: Mar, 2034)
|
REGENERON PHARMACEUTICALS
(and 1 more)
| |
| EP3088373B1 | Translucent Zirconia Sintered Body And Zirconia Powder, And Use Therefor | TOSOH |
27 Aug, 2020
|
TREIBACHER INDUSTRIE
| |
| EP2596786B1 | Use Of Eicosapentaenoic Acid Ethyl Ester For Treating Hypertriglyceridemia | AMARIN PHARMACEUTICALS IRELAND LTD |
26 Aug, 2020
(Expiration: Feb, 2030)
|
HOFFMANN EITLE
(and 1 more)
| |
| EP3037089B1 | Eicosapentaenoic Acid Ethyl Ester For Treating Hypertriglyceridemia | AMARIN PHARMACEUTICALS IRELAND LTD |
26 Aug, 2020
(Expiration: Feb, 2030)
|
HOFFMANN EITLE
(and 1 more)
| |
| EP3188717B1 | Formulation Comprising Particles | PERORA GMBH |
21 Aug, 2020
(Expiration: Aug, 2035)
|
DSM NUTRITIONAL PRODUCTS
| |
| EP3456374B1 | Implant Syringe | GAPLAST GMBH |
20 Aug, 2020
(Expiration: Aug, 2038)
|
AMW
| |
| EP3278809B1 | Safe Desmopressin Administration | SERENITY PHARMACEUTICALS LLC |
20 Aug, 2020
(Expiration: Jun, 2030)
|
FERRING
| |
| EP3275422B1 | Aqueous Hair Styling Composition Comprising High Amounts Of Waxes And Fatty Compounds | KAO GERMANY |
20 Aug, 2020
|
HENKEL
| |
| EP3272361B1 | Method For Producing A Freeze-Dried Pharmaceutical Composition Containing Mitomycin C | MEDAC GESELLSCHAFT FR KLINISCHE SPEZIALPRPARATE |
20 Aug, 2020
|
HOLLATZ
| |
| EP3174889B1 | Sofosbuvir In Crystalline Form And Process For Its Preparation | HC PHARMA |
20 Aug, 2020
|
KELTIE
| |
| EP3137043B2 | Sunscreen Having Reduced Tendency To Stain Textiles Iv | BEIERSDORF |
20 Aug, 2020
|
LOREAL
(and 1 more)
| |
| EP1827604B1 | Methods And Compositions For Adoptive Immunotherapy | PETER MACCALLUM CANCER INSTITUTE |
19 Aug, 2020
(Expiration: Dec, 2025)
|
GLAXOSMITHKLINE
(and 2 more)
| |
| EP3172319B1 | Coronavirus | THE PIRBRIGHT INSTITUTE |
19 Aug, 2020
|
MUSEBENI
| |
| EP2781509B2 | New Polymorph Of Ivabradine Hydrochloride And Method For Its Preparation | CHEMO RESEARCH SL |
18 Aug, 2020
|
BOTTI & FERRARI
| |
| EP3409274B1 | Dosage Regimen For A S1P Receptor Agonist | NOVARTIS AG |
18 Aug, 2020
(Expiration: Dec, 2029)
|
VON SEEBACH
(and 1 more)
| |
| EP3409286B1 | Low Frequency Glatiramer Acetate Therapy | YEDA RESEARCH AND DEVELOPMENT CO LTD |
17 Aug, 2020
(Expiration: Aug, 2030)
|
GENERICS UK
(and 1 more)
| |
| EP3363807B1 | Pharmaceutical Composition Comprising Crystalline (2S,3R,4S,5S,6R)-2-[4-Chloro-3-(4-Ethoxy-Benzyl)-Phenyl]-6-Hydroxymethyl-2-Methoxy-Tetrahydro-Pyran-3,4,5-Triol (S)-Propylene Glycol Solvate | ASTRAZENECA |
13 Aug, 2020
(Expiration: Jun, 2027)
|
GENERICS UK
| |
| EP3448302B1 | A Method Of Making A Dental Restoration | SOLVENTUM PROPERTIES |
13 Aug, 2020
|
IVOCLAR VIVADENT
| |
| EP3245257B2 | Surface-Treated Calcium Carbonate With Improved Stability In Environments With A Ph Of 4.5 To 7 | OMYA |
13 Aug, 2020
|
SCHAEFER KALK
| |
| EP2794024B2 | Coloring Agent Comprising Direct Dyes And Amphoteric Surfactants | HENKEL |
12 Aug, 2020
|
LOREAL
| |
| EP2978426B1 | Stable Tigecycline Composition | INTAS PHARMACEUTICALS |
11 Aug, 2020
|
FRESENIUS MEDICAL CARE DEUTSCHLAND
| |
| EP2906547B2 | Cosmetic Compositions Containing At Least One Hydrotrope And At Least One Active Compound | LORAL |
11 Aug, 2020
|
HENKEL
| |
| EP2767285B1 | Tablet Including 7-[4-(4-Benzo[Beta]Thiophen-4-Yl-Piperazin-1-Yl) Butoxy]-1H-Quinolin-2-One Or Salt Thereof | OTSUKA PHARMACEUTICAL |
11 Aug, 2020
|
MAIWALD PATENT UND RECHTSANWALTSGESELLSCHAFT
(and 1 more)
| |
| EP3263571B2 | Crystal Form Of (R)-N-Methylnaltrexone Bromide And Uses Thereof | PROGENICS PHARMACEUTICALS |
10 Aug, 2020
|
ISARPATENT PATENT UND RECHTSANWLTE BEHNISCH BARTH CHARLES HASSA PECKMANN UND PARTNER MBB
| |
| EP3246021B1 | Apixaban Formulations | BRISTOL MYERS SQUIBB IRELAND UNLIMITED |
07 Aug, 2020
|
ALFRED E TIEFENBACHER
(and 11 more)
| |
| EP3043658B1 | Nutritional Composition Having Lipophilic Compounds With Improved Solubility And Bioavailability | ABBOTT LABORATORIES |
07 Aug, 2020
|
NUTRICIA
| |
| EP1591105B1 | Use Of Antioxidants For The Preparation Of Pharmaceutical Or Cosmetic Compositions For Protecting The Skin From Damages By Infrared-Radiations | STADA ARZNEIMITTEL AG |
06 Aug, 2020
(Expiration: Mar, 2025)
|
EMIL KIESSLING
(and 5 more)
| |
| EP3319693B2 | Method Of Strengthening Hair Fibers And Protecting Dyed Hair Color From Fading Or Wash-Out | HERCULES |
06 Aug, 2020
|
HENKEL
| |
| EP3137041B2 | Sunscreen Having Reduced Tendency To Stain Textiles I | BEIERSDORF |
06 Aug, 2020
|
LOREAL
| |
| EP2934189B1 | Human Milk Oligosaccharides To Ameliorate Symptoms Of Stress | ABBOTT LABORATORIES |
06 Aug, 2020
(Expiration: Dec, 2033)
|
SOCIT DES PRODUITS NESTL
| |
| EP3233043B1 | Process For Preparing Hydrogels | TEOXANE |
05 Aug, 2020
|
ALLERGAN
(and 1 more)
| |
| EP3566695B1 | Treatment Of Coccidiosis With Intramuscular Triazine Compositions | CEVA SANTE ANIMALE SA |
05 Aug, 2020
(Expiration: Dec, 2033)
|
BAYER ANIMAL HEALTH
(and 1 more)
| |
| EP2898061B1 | Probiotic Compositions And Methods For The Treatment Of Obesity And Obesity-Related Conditions | PROTHERA INC |
05 Aug, 2020
(Expiration: Aug, 2033)
|
COMPAGNIE GERVAIS DANONE
| |
| EP3302565B1 | Solid Dosage Forms Of Palbociclib | PFIZER INC |
05 Aug, 2020
(Expiration: May, 2036)
|
HEXAL
(and 5 more)
| |
| EP3386994B1 | 4,6-Di-(O-Thiophosphate)-Inositol-1,2,3,5-Tetra-O-Sulfate For C. Difficile Infection | ETH ZRICH |
05 Aug, 2020
|
HGF
| |
| EP2905030B1 | Human Antibodies That Bind Lymphocyte Activation Gene-3 (Lag-3) And Uses Thereof | E R SQUIBB & SONS |
05 Aug, 2020
|
REGENERON PHARMACEUTICALS
| |
| EP3288931B2 | Certain Protein Kinase Inhibitor | CHONGQING FOCHON PHARMACEUTICAL |
04 Aug, 2020
|
HANN MOORE CURLEY
| |
| EP1856051B1 | Amorphous Lercanidipine Hydrochloride | RECORDATI IRELAND LTD |
04 Aug, 2020
(Expiration: Feb, 2026)
|
HEUMANN PHARMA GENERICA
(and 6 more)
| |
| EP1874873B1 | Sparkle Effect Of Unique Particle Size Distribution | BASF |
31 Jul, 2020
|
ECKART
| |
| EP2862561B1 | Method For Conditioning Hair With An Aerosol Cream Mousse | THE PROCTER & GAMBLE |
30 Jul, 2020
|
KAO GERMANY
| |
| EP2862560B1 | Aerosol Cream Mousse, Method Of Treating Hair And Use | THE PROCTER & GAMBLE |
30 Jul, 2020
|
KAO GERMANY
| |
| EP3456342B1 | Agent For Use In The Case Of Fructose Intolerance | VITACARE |
30 Jul, 2020
|
STADA ARZNEIMITTEL
| |
| EP3142637B1 | Keratin Treatment Formulations And Methods | OLAPLEX |
29 Jul, 2020
|
LORAL
| |
| EP2346355B1 | Nutritional Compositions With Lipid Globules With A Core Comprising Vegetable Lipids And A Coating Comprising Phospholipids Or Polar Lipids | NUTRICIA NV |
24 Jul, 2020
(Expiration: Sep, 2029)
|
FRESENIUS KABI DEUTSCHLAND
| |
| EP3083686B2 | Methods Of Treating Cancers Using Pd-1 Axis Binding Antagonists And Taxanes | F HOFFMANN LA ROCHE AG |
23 Jul, 2020
(Expiration: Dec, 2034)
|
ARES TRADING
(and 2 more)
| |
| EP3338751B1 | Absorbent Structure For Absorbent Articles | THE PROCTER & GAMBLE |
23 Jul, 2020
|
KIMBERLY CLARK WORLDWIDE
(and 1 more)
| |
| EP2349332B1 | Methods And Compositions For Regulating Iron Homeostasis By Modulation Bmp-6 | GENERAL HOSPITAL CORP |
23 Jul, 2020
(Expiration: Nov, 2029)
|
MATHYS & SQUIRE
| |
| EP3033102B2 | Peptide Conjugated Particles | NORTHWESTERN UNIVERSITY |
23 Jul, 2020
|
PHOSPHOREX
| |
| EP3269802B1 | Compounds For Improved Viral Transduction | BLUEBIRD BIO |
23 Jul, 2020
|
SCRIPT
(and 1 more)
| |
| EP3145488B1 | Liquid Pharmaceutical Composition | FRESENIUS KABI DEUTSCHLAND GMBH |
22 Jul, 2020
(Expiration: May, 2035)
|
BIOGEN
(and 2 more)
| |
| EP3041476B2 | Corticosteroid Containing Orally Disintegrating Tablet Compositions For Eosinophilic Esophagitis | ELLODI PHARMACEUTICALS LP |
22 Jul, 2020
|
DR FALK PHARMA
| |
| EP2252289B1 | Combination Therapy Comprising Sglt Inhibitors And Dpp4 Inhibitors | MITSUBISHI TANABE PHARMA |
22 Jul, 2020
|
ELKINGTON AND FIFE
| |
| EP2877144B1 | Composition | UNILEVER |
22 Jul, 2020
|
HENKEL
| |
| EP2233127B1 | Use Of Antioxidants For The Preparation Of Pharmaceutical Or Cosmetic Compositions For Protecting The Skin From Damages By Infrared-Radiations | STADA ARZNEIMITTEL AG |
21 Jul, 2020
(Expiration: Mar, 2025)
|
DIRK ROSSMANN
(and 7 more)
| |
| EP3313364B1 | Hair Treatment Process | KAO GERMANY |
17 Jul, 2020
|
HENKEL
(and 1 more)
| |
| EP2059258B1 | Arginine Wash In Protein Purification Using Affinity Chromatography | WYETH LLC |
17 Jul, 2020
(Expiration: Sep, 2027)
|
J A KEMP
(and 1 more)
| |
| EP2496220B1 | Modified Release Formulation Of Lacosamide | LUPIN |
16 Jul, 2020
|
JAMES POOLE
| |
| EP2792715B1 | Semi-Synthetic Or Synthetic Vaselines | AIGLON |
16 Jul, 2020
(Expiration: Mar, 2034)
|
SASOL WAX
| |
| EP3285733B1 | Methods For Treating Relaxed Hair | OLAPLEX |
14 Jul, 2020
|
HENKEL
| |
| EP2785349B2 | Combination Treatment Of Cancer | ASTRAZENECA |
14 Jul, 2020
(Expiration: Nov, 2032)
|
TEVA PHARMACEUTICAL INDUSTRIES
| |
| EP3126390B1 | Cd33 Specific Chimeric Antigen Receptors For Cancer Immunotherapy | CELLECTIS |
14 Jul, 2020
|
WUESTHOFF & WUESTHOFF PATENTANWLTE PARTG MBB
| |
| EP3113847B1 | Anhydrous Dyeing Composition And Process For Dyeing Hair | KAO GERMANY |
13 Jul, 2020
|
HENKEL
| |
| EP3251660B1 | Apixaban Formulations | BRISTOL MYERS SQUIBB IRELAND UNLIMITED |
13 Jul, 2020
|
KUTZENBERGER WOLFF & PARTNER
(and 9 more)
| |
| EP3331537B1 | Prophylactic Use Of Inulin Against Sinusitis | SDZUCKER |
09 Jul, 2020
|
DEHMEL & BETTENHAUSEN PATENTANWLTE PARTMBB
| |
| EP2504002B1 | Treatment Of Genotyped Diabetic Patients With Dpp-Iv Inhibitors Such As Linagliptin | BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
09 Jul, 2020
(Expiration: Nov, 2030)
|
ELKINGTON AND FIFE
(and 1 more)
| |
| EP3300729B1 | Therapeutic Compositions Containing Macitentan | ACTELION PHARMACEUTICALS |
09 Jul, 2020
|
GENERICS UK
(and 2 more)
| |
| EP3030262B1 | Combined Pharmaceutical Composition | CYTUNE PHARMA |
09 Jul, 2020
|
MARGARET DIXON
| |
| EP2928496B1 | Crispr-Based Genome Modification And Regulation | SIGMA ALDRICH CO LLC |
09 Jul, 2020
(Expiration: Dec, 2033)
|
PATENTANWLTE ISENBRUCK BSL HRSCHLER PARTG MBB
(and 7 more)
| |
| EP2906696B2 | Methods For Modulating C9Orf72 Expression | IONIS PHARMACEUTICALS |
09 Jul, 2020
|
RICHLY
(and 1 more)
| |
| EP3202914B2 | Method For Diagnosing A Neurodegenerative Disease | THE UNIVERSITY OF MANCHESTER |
09 Jul, 2020
|
STRAWMAN
| |
| EP2806877B1 | Neuroactive Steroid Formulations And Methods Of Treating Cns Disorders | SAGE THERAPEUTICS |
08 Jul, 2020
|
DR SCHN
| |
| EP2337472B1 | A Cosmetic Or Dermatological System With Automatic Adjustment Of The Properties Of A Preparation As A Function Of Data Transmitted By A Transmitter External To The System | LOREAL SA |
08 Jul, 2020
(Expiration: Oct, 2029)
|
HENKEL
(and 1 more)
| |
| EP3192880B1 | Nucleic Acid Agents For Use In Treating Facioscapulohumeral Dystrophy (Fshd) | LEIDS UNIVERSITAIR MEDISCH CENTRUM LUMC |
08 Jul, 2020
(Expiration: Aug, 2031)
|
STRAWMAN
(and 1 more)
| |
| EP2187965B1 | Psma Binding Ligand-Linker Conjugates And Methods For Using | PURDUE RESEARCH FOUNDATION |
07 Jul, 2020
(Expiration: Aug, 2028)
|
BOULT WADE TENNANT
(and 1 more)
| |
| EP3038654B1 | New Use | NOVARTIS AG |
06 Jul, 2020
(Expiration: Aug, 2034)
|
GENERICS UK
(and 8 more)
| |
| EP2196225B1 | Water-Soluble Agents In Acrylate-Based Preparations | BEIERSDORF |
06 Jul, 2020
|
HENKEL
(and 1 more)
| |
| EP3274685B1 | Process For Evaluating The Mechanical Performance Of A Filler Gel | TEOXANE |
02 Jul, 2020
|
ALLERGAN
| |
| EP3334289B1 | High Throughput Process For Delivering Semi-Firm Gel For Poultry | CLEARHO |
02 Jul, 2020
|
CEVA SANTE ANIMALE
| |
| EP2694050B1 | Tapentadol For Treating Pain Associated With Trigeminal Neuralgia | GRNENTHAL |
02 Jul, 2020
|
GENERICS UK
| |
| EP2684565B1 | Use Of Ulipristal Acetate For Treating Uterine Fibroids | LABORATOIRE HRA PHARMA SAS |
02 Jul, 2020
(Expiration: Jan, 2029)
|
HOFFMAN EITLE PATENT UND RECHTSANWLTE PARTNERSCHAFTSGESELLSCHAFT MBB
(and 1 more)
| |
| EP3389404B1 | Mixture Of Hmos | SOCIT DES PRODUITS NESTL |
02 Jul, 2020
|
NUTRICIA
(and 1 more)
| |
| EP3041454B2 | Powder Mixture, Use Of The Powder Mixture And Powder Jet Device | FERTON HOLDING |
02 Jul, 2020
|
OROCHEMIE
(and 1 more)
| |
| EP3257500B1 | Apixaban Formulations | BRISTOL MYERS SQUIBB IRELAND UNLIMITED |
02 Jul, 2020
|
ZAKLADY FARMACEUTYCZNE POLPHARMA
(and 9 more)
| |
| EP3016631B1 | Cosmetic Composition | LOREAL |
01 Jul, 2020
|
BEIERSDORF
| |
| EP2978440B1 | Treating Fibrosis And Inflammation By Inhibiting Tl1A | CEDARS SINAI MEDICAL CENTER |
01 Jul, 2020
(Expiration: Mar, 2034)
|
STRAWMAN
| |
| EP3236985B2 | Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Hepatocellular Carcinoma (Hcc) And Other Cancers | IMMATICS BIOTECHNOLOGIES |
25 Jun, 2020
|
ADAPTIMMUNE
| |
| EP2783689B1 | Keratoconjunctival Protecting Agent, Or Keratoconjunctival Disorder Inhibiting Agent | TOYO SUGAR REFINING |
25 Jun, 2020
|
BITOP
| |
| EP3340990B1 | Pharmaceutical Combinations Comprising (A) The Cyclin Dependent Kinase 4/6 (Cdk4/6) Inhibitor Lee011 (=Ribociclib), And (B) The Epidermal Growth Factor Receptor (Egfr) Inhibitor Erlotinib, For The Treatment Or Prevention Of Cancer | NOVARTIS AG |
25 Jun, 2020
(Expiration: Aug, 2036)
|
GENERICS UK
| |
| EP3180363B2 | Sirp-Alpha Immunoglobulin Fusion Proteins | MERCK PATENT |
24 Jun, 2020
|
SCRIPT
| |
| EP3227342B2 | Proteinaceous Heterodimer And Use Thereof | DINGFU BIOTARGET |
18 Jun, 2020
|
MARGARET DIXON
| |
| EP2538975B1 | Immunoglobulin Preparation And Storage System For An Immunoglobulin Preparation | CSL BEHRING |
18 Jun, 2020
|
OCTAPHARMA
| |
| EP3050963B1 | Process For Production Of Polypeptide By Regulation Of Assembly | CHUGAI SEIYAKU KABUSHIKI KAISHA |
18 Jun, 2020
|
SANOFI
(and 1 more)
| |
| EP3065571B1 | Composition | PROBIOTIX HEALTH |
12 Jun, 2020
|
CLASADO BIOSCIENCES
| |
| EP3174526B2 | Composition Containing Apomorphine And A Divalent Metal Cation | BRITANNIA PHARMACEUTICALS |
10 Jun, 2020
|
EVER NEURO PHARMA
| |
| EP2780375B1 | Binding Molecules For Bcma And Cd3 | AMGEN RESEARCH MUNICH |
10 Jun, 2020
|
TENEOBIO
(and 7 more)
| |
| EP3341173B1 | Mixing And Molding Method For Filled Thermosets From Organically Crosslinkable Composite Materials, In Particular For Dental Purposes | WOLTER HERBERT |
08 Jun, 2020
|
SPLANEMANN PATENTANWLTE PARTNERSCHAFT
| |
| EP3170842B1 | Immunologic Effector Cell Of Targeted Cld18A2, And Preparation Method And Use Thereof | CRAGE MEDICAL |
04 Jun, 2020
|
BIONTECH CELL & GENE THERAPIES
| |
| EP3303307B1 | New Gadolinium Chelate Compounds For Use In Magnetic Resonance Imaging | BAYER PHARMA |
04 Jun, 2020
|
DE SIMONE & PARTNERS
| |
| EP3021691B1 | Methods And Systems For Incorporating Nicotine Into Oral Products | ALTRIA CLIENT SERVICES |
04 Jun, 2020
|
FERTIN PHARMA
| |
| EP3295925B2 | Composition For The Permanent Deformation Of Hair Having Reduced Odour | NOXELL |
04 Jun, 2020
|
HENKEL
| |
| EP3313452B1 | Method For Preparing An Injectable Cross-Linked Hydrogel, Hydrogel Obtained; And Use Of The Obtained Hydrogel | KYLANE LABORATOIRES |
04 Jun, 2020
|
LABORATOIRES VIVACY
(and 1 more)
| |
| EP2547402B2 | Hair Care Products Containing Conjugated Unsaturated Oils | KAO |
04 Jun, 2020
|
LORAL
(and 1 more)
| |
| EP3082959B1 | Cosmetic Hair Cleaning Composition | HENKEL |
03 Jun, 2020
|
LOREAL
(and 1 more)
| |
| EP3300724B1 | Particle Containing At Least A Volatile Substance And Process For Its Preparation | ERBER |
02 Jun, 2020
|
LEDERER & KELLER PATENTANWLTE PARTNERSCHAFT MBB
| |
| EP3091071B1 | Methods For Cell Expansion And Uses Of Cells And Conditioned Media Produced Thereby For Therapy | PLURISTEM |
02 Jun, 2020
|
STRAWMAN
| |
| EP3064508B2 | Method Of Producing Recombinant High Molecular Weight Vwf In Cell Culture | BAXALTA |
28 May, 2020
|
JAMES POOLE
| |
| EP3346995B1 | Therapeutic Compositions For Treatment Of Human Immunodeficiency Virus | GILEAD SCIENCES |
28 May, 2020
|
SANDOZ
(and 2 more)
| |
| EP3116527B1 | Method For Preparing Human Plasma Proteins | LFB SA |
27 May, 2020
(Expiration: Mar, 2035)
|
CSL BEHRING
| |
| EP3272397B1 | Agent For Oxidative Hair Dye And Method For Stabilizing Color Tone Of Oxidative Hair Dye Composition | HOYU CO LTD |
25 May, 2020
(Expiration: Jul, 2037)
|
HENKEL
(and 1 more)
| |
| EP3261485B1 | Cosmetic Product Having A Metal Can, And The Contents Of Same | BEIERSDORF AG |
25 May, 2020
(Expiration: Feb, 2036)
|
HENKEL
| |
| EP3186395B2 | Engraftment Of Stem Cells With A Combination Of An Agent That Targets Stem Cells And Modulation Of Immunoregulatory Signaling | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY |
25 May, 2020
|
HOFFMAN EITLE PATENT UND RECHTSANWLTE PARTNERSCHAFTSGESELLSCHAFT MBB
| |
| EP3024450B1 | Compositions And Methods Using Tiglic Aldehyde | SOCIT DES PRODUITS NESTL |
25 May, 2020
|
NUTRICIA
| |
| EP3210592B1 | Silica And Dentifrice Composition Comprising The Same | EVONIK DEGUSSA GMBH |
25 May, 2020
(Expiration: Feb, 2031)
|
PQ PQ SILICAS UK
| |
| EP3319587B1 | Novel Pharmaceutical Composition Comprising Particles Comprising A Complex Of A Double-Stranded Polyribonucleotide And A Polyalkyleneimine | HIGHLIGHT THERAPEUTICS SL |
25 May, 2020
|
TARGIMMUNE THERAPEUTICS
| |
| EP3081208B1 | Skin Care Spray Compositions Comprising Microfibrillated Cellulose | BORREGAARD |
25 May, 2020
|
WEIDMANN HOLDING
| |
| EP2773334B1 | Composition With Sustained Antimicrobial Activity | COLUMBIA UNIVERSITY OF NEW YORK |
22 May, 2020
(Expiration: Nov, 2032)
|
HENKEL
| |
| EP2780374B1 | Binding Molecules For Bcma And Cd3 | AMGEN RESEARCH MUNICH GMBH |
22 May, 2020
(Expiration: Nov, 2032)
|
KNIG SZYNKA TILMANN VON RENESSE
(and 6 more)
| |
| EP2498756B2 | Tablet Formulations Of Neratinib Maleate | WYETH |
21 May, 2020
|
COOKE
| |
| EP2874624B8 | Injectable Antibiotic Formulations And Their Methods Of Use | ELANCO NEW ZEALAND |
21 May, 2020
|
OMNIPHARM DEVELOPMENTS
(and 1 more)
| |
| EP2928455B1 | Treatment Of Coccidiosis With Intramuscular Triazine Compositions | CEVA SANT ANIMALE |
20 May, 2020
|
BAYER ANIMAL HEALTH
(and 1 more)
| |
| EP3395331B1 | Pharmaceutical Tablet Composition Comprising Eltrombopag Olamine | ALFRED E TIEFENBACHER GMBH AND CO KG |
20 May, 2020
(Expiration: Jul, 2037)
|
BLLE DR
| |
| EP2614835B1 | Vaccination With Multiple Clades Of H5 Influenza A Virus | SEQIRUS UK LTD |
20 May, 2020
(Expiration: Nov, 2028)
|
GLAXOSMITHKLINE BIOLOGICALS
| |
| EP3049108B2 | Dry Formulations Of Vaccines That Are Room Temperature Stable | INTERVET |
20 May, 2020
|
MAIWALD PATENTANWALTS UND RECHTSANWALTSGESELLSCHAFT
| |
| EP2964215B1 | Mixture Of Fatty Acids For Use In The Treatment Of Inflammatory Pathologies | AGAIN LIFE ITALIA |
20 May, 2020
|
NUTRICIA
| |
| EP2266422B1 | Synergism Of Gos And Polyfructose | NUTRICIA NV |
20 May, 2020
(Expiration: May, 2025)
|
SOCIT DES PRODUITS NESTL
| |
| EP2846761B1 | Composition Comprising (2,5-Diaminophenyl)Ethanol, An Alkylpolyglucoside Nonionic Surfactant, An Oxyethylenated Sorbitan Ester Or A Polyalkoxylated Or Polyglycerolated Fatty Alcohol In A Medium Rich In Fatty Substances, Dyeing Process And Device Therefore | LOREAL |
19 May, 2020
|
HENKEL
| |
| EP3283050B1 | Hair Dyeing Composition | KAO GERMANY |
19 May, 2020
|
LORAL
| |
| EP3031920B1 | Modulation Of Dystrophia Myotonica-Protein Kinase (Dmpk) Expression | IONIS PHARMACEUTICALS INC |
19 May, 2020
(Expiration: Jul, 2031)
|
STRAWMAN
| |
| EP3141284B1 | Method Of Straightening Keratinous Fibers Using Heating Means And An Acid Derivative | LORAL |
18 May, 2020
|
HENKEL
| |
| EP3148646B2 | Cosmetic Composition For Make Up And For Taking Care Of Keratin Materials | LORAL |
15 May, 2020
|
HENKEL
| |
| EP3225233B1 | Sodium Chloride Solution For Drug Reconstitution Or Dilution | WYETH LLC |
14 May, 2020
(Expiration: Oct, 2026)
|
BIOVERATIV THERAPEUTICS
(and 1 more)
| |
| EP3133070B1 | Eliglustat (Genz 112638) As Inhibitor Of Glucosylceramide Synthase For Use In A Method Of Treating Fabry'S Or Gaucher'S Disease, The Method Comprising Adjusting The Individual Therapeutical Dose To The P-450 Metabolism Of The Patient | GENZYME |
14 May, 2020
|
HETERO LABS
(and 2 more)
| |
| EP3024461B1 | A Combination Of Oxycodone And Naloxone For Use In Treating Pain In Patients Suffering From Pain And A Disease Resulting In Intestinal Dysbiosis And/Or Increasing The Risk For Intestinal Bacterial Translocation | EURO CELTIQUE SA |
14 May, 2020
(Expiration: Jul, 2034)
|
HEXAL PHARMA
(and 1 more)
| |
| EP2970123B1 | Salt Of Omecamtiv Mecarbil And Process For Preparing Salt | AMGEN |
14 May, 2020
|
KELTIE
| |
| EP3273957B1 | Biotin For Treating Amyotrophic Lateral Sclerosis | MEDDAY PHARMACEUTICALS |
14 May, 2020
|
NUTRICIA
| |
| EP2676967B1 | Methods Of Treating Inflammatory And Autoimmune Diseases With Natalizumab | BIOGEN MA INC |
14 May, 2020
(Expiration: Feb, 2027)
|
POLPHARMA BIOLOGICS
| |
| EP3143985B1 | Use Of Probiotic Microorganisms To Reduce Skin Irritation | SOCIETE DES PRODUITS NESTLE SA |
14 May, 2020
(Expiration: Mar, 2030)
|
SOFAR
(and 2 more)
| |
| EP3436054B2 | Stabilized Non-Protein Clostridial Toxin Compositions | ALLERGAN |
12 May, 2020
|
IPSEN PHARMA
| |
| EP3432916B1 | Stabilized Non-Protein Clostridial Toxin Compositions | ALLERGAN |
12 May, 2020
|
IPSEN PHARMA
| |
| EP2621481B2 | Dual Inhibitors Of Met And Vegf For The Treatment Of Castration- Resistant Prostate Cancer And Osteoblastic Bone Metastases | EXELIXIS |
12 May, 2020
|
TEVA PHARMACEUTICAL INDUSTRIES
| |
| EP3116535B1 | Combination Of Vaccination And Ox40 Agonists | CUREVAC |
07 May, 2020
|
BIONTECH RNA PHARMACEUTICALS
| |
| EP3087095B1 | Fcrn Antagonists And Methods Of Use | ARGENX BVBA |
07 May, 2020
|
SANOFI
| |
| EP2869843B1 | Complexes Of Cytomegalovirus Proteins | GLAXOSMITHKLINE BIOLOGICALS |
07 May, 2020
(Expiration: Jun, 2033)
|
SANOFI PASTEUR
(and 1 more)
| |
| EP3160428B1 | A Sebum-Promoting Agent For Improving Hair | UNILEVER PLC |
07 May, 2020
(Expiration: Jun, 2035)
|
THE PROCTER & GAMBLE
| |
| EP2266549B1 | Method Of Making Particles For Use In A Pharmaceutical Composition | VECTURA LTD |
06 May, 2020
(Expiration: Jun, 2021)
|
GLAXO GROUP
| |
| EP2713998B2 | Process For Treating Straightened Keratin Fibres | LOREAL |
06 May, 2020
|
HENKEL
| |
| EP2679681B2 | Fc Riib-Specific Fc Antibody | CHUGAI SEIYAKU KABUSHIKI KAISHA |
06 May, 2020
|
HGF
| |
| EP3018211B1 | Antisense Nucleic Acids | NIPPON SHINYAKU CO LTD |
06 May, 2020
(Expiration: Aug, 2031)
|
SAREPTA THERAPEUTICS
(and 1 more)
| |
| EP2371361B1 | Methods To Mobilize Progenitor/Stem Cells | GENZYME |
06 May, 2020
|
TEVA PHARMACEUTICAL INDUSTRIES
(and 6 more)
| |
| EP2651400B2 | Controlled Release Oral Dosage Forms Of Poorly Soluble Drugs And Uses Thereof | AMGEN EUROPE |
06 May, 2020
|
TEVA PHARMACEUTICAL INDUSTRIES
| |
| EP2419144B1 | Composition For Delivery Of Genetic Material | OXFORD UNIVERSITY INNOVATION |
06 May, 2020
|
TRUSCOTT
(and 1 more)
| |
| EP3342411B1 | Rapamycin Derivative For Treating Pancreas Cancer | NOVARTIS PHARMA AG |
05 May, 2020
(Expiration: Feb, 2022)
|
GENERICS UK
(and 9 more)
| |
| EP2292252B1 | Unitary Combination Of Fsh And Hcg | FERRING BV |
05 May, 2020
(Expiration: Jun, 2024)
|
MERCK SERONO
| |
| EP3027186B1 | Composition Comprising Hyaluronic Acid And Mepivacaine | TEOXANE |
04 May, 2020
|
LABORATOIRES VIVACY
(and 2 more)
| |
| EP2635299B1 | Methods For Treating Hair Loss Disorders | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK |
30 Apr, 2020
|
CONCERT PHARMACEUTICALS
| |
| EP3066472B1 | Compositions And Methods For Detecting And/Or Treating Inflammation | THE GENERAL HOSPITAL |
30 Apr, 2020
|
DR H ULRICH DRRIES
| |
| EP3150610B1 | Salts And Polymorphs Of 8-Fluoro-2-{4-[(Methylamino}Methyl]Phenyl}-1,3,4,5-Tetrahydro-6H-Azepino[5,4,3-Cd]Indol-6-One | PFIZER INC |
30 Apr, 2020
(Expiration: Feb, 2031)
|
GENERICS UK
| |
| EP3372093B2 | Process For Obtaining Citrus Fiber From Citrus Peel | CARGILL INCORPORATED |
30 Apr, 2020
|
HERBSTREITH & FOX PECTIN FABRIKEN
(and 1 more)
| |
| EP3240554B1 | Compositions Comprising Bacterial Strains | 4D PHARMA RESEARCH LTD |
30 Apr, 2020
(Expiration: Jun, 2036)
|
HOFFMANN EITLE
| |
| EP2950816B1 | The Use Of Dna Sequences Encoding An Interferon As Vaccine Adjuvants | SCHWEITZER BIOTECH CO LTD |
30 Apr, 2020
(Expiration: Feb, 2034)
|
ZOETIS SERVICES
| |
| EP3316854B1 | Composition Comprising Multiple Populations Of Microcapsules Comprising Perfume | THE PROCTER & GAMBLE |
29 Apr, 2020
|
HENKEL
(and 1 more)
| |
| EP2760425B8 | Foam Oxidative Hair Colorant Composition With The Free-Base Of 1, 4-Diamino-2-Methoxmethyl Benzene | NOXELL CORP |
29 Apr, 2020
(Expiration: Sep, 2032)
|
HENKEL
| |
| EP3403654B1 | Orally Administered Corticosteroid Compositions | ELLODI PHARMACEUTICALS LP |
28 Apr, 2020
|
DR FALK PHARMA
| |
| EP3137042B1 | Sunscreen Having Reduced Tendency To Stain Textiles Ii | BEIERSDORF |
28 Apr, 2020
|
LOREAL
| |
| EP2588589B2 | Detergent Product | THE PROCTER & GAMBLE |
27 Apr, 2020
|
HENKEL
| |
| EP3027174B1 | Pharmaceutical Compositions Of Fingolimod | AIZANT DRUG RES SOLUTIONS PRIVATE LTD |
24 Apr, 2020
(Expiration: Dec, 2033)
|
DF MP DRRIES FRANK MOLNIA & POHLMAN
| |
| EP2897611B1 | Methods For Treating Hepatitis C | ABBVIE |
24 Apr, 2020
|
LUIGI
| |
| EP2991675B1 | Campylobacter Vaccine | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA |
23 Apr, 2020
|
DR KASCHE
| |
| EP3384931B1 | Formoterol Superfine Formulation | CHIESI FARMACEUTICI |
23 Apr, 2020
|
LUPIN HEALTHCARE UK
| |
| EP2282764B1 | Liver-Specific Nucleic Acid Regulatory Elements And Methods And Use Thereof | VIB VZW |
23 Apr, 2020
|
PFIZER
(and 1 more)
| |
| EP2768484B1 | Lyophilized Liposomes | JAZZ PHARMACEUTICALS RESEARCH |
23 Apr, 2020
|
SANDOZ
(and 1 more)
| |
| EP3210610B1 | Formulations Containing Triazinones And Iron | BAYER ANIMAL HEALTH |
22 Apr, 2020
|
CEVA SANTE ANIMALE
| |
| EP2784084B2 | Il-17 A/F Heterologous Polypeptides And Therapeutics Uses Thereof | NOVARTIS PHARMA AG |
22 Apr, 2020
(Expiration: Jun, 2024)
|
MERCK PATENT
(and 3 more)
| |
| EP2991507B1 | Use Of A Composition Comprising Fish Oil And Juice For The Treatment And/Or Post Treatment Of Cancer | SMARTFISH |
22 Apr, 2020
|
NUTRICIA
| |
| EP3370683B1 | Antiperspirant Compositions | UNILEVER |
22 Apr, 2020
|
THE PROCTER & GAMBLE
| |
| EP3093006B1 | Alcohol Containing Sunscreen Product Without Octocrylene | BEIERSDORF |
21 Apr, 2020
|
BASF
(and 2 more)
| |
| EP3103448B1 | Pharmaceutical Compositions Comprising An S1P Modulator | NOVARTIS |
20 Apr, 2020
(Expiration: Sep, 2027)
|
KRAUS & WEISERT PATENTANWLTE PARTGMBB
(and 6 more)
| |
| EP2651249B1 | Whey Protein Composition With A Reduced Astringency | NUTRICIA |
20 Apr, 2020
|
SOCIT DES PRODUITS NESTL
(and 1 more)
| |
| EP3199146B1 | Risperidone Sustained Release Microsphere Composition | SHAN DONG LUYE PHARMACEUTICAL |
17 Apr, 2020
|
ALKERMES PHARMA IRELAND
(and 1 more)
| |
| EP3326641B1 | Rna Containing Composition For Treatment Of Tumor Diseases | CUREVAC |
17 Apr, 2020
|
FRIEDRICH
(and 3 more)
| |
| EP3072499B1 | Octocrylene-Free Sunscreen With Low Adhesion | BEIERSDORF AG |
17 Apr, 2020
(Expiration: Jan, 2035)
|
LOREAL
(and 2 more)
| |
| EP3110433B2 | Treatment Of Retinal Degeneration Using Gene Therapy | THE UNIVERSITY OF MANCHESTER |
17 Apr, 2020
|
STRATAGEM
(and 1 more)
| |
| EP2832350B1 | Method For Producing Disintegrating Particulate Composition Comprising Acid-Type Carboxymethylcellulose, Disintegrating Particulate Composition Comprising Acid-Type Carboxymethylcellulose, And Orally Disintegrating Tablet Including Disintegrating Particulate Composition Comprising Acid-Type Carboxymethylcellulose | DAICEL |
16 Apr, 2020
|
BAYER BAYER BAYER PHARMA
| |
| EP2814450B1 | Stable Water-In-Oil Emulsions With Hlb-Type Emulsifiers | BEIERSDORF AG |
16 Apr, 2020
(Expiration: Feb, 2033)
|
EVONIK OPERATIONS
| |
| EP3093008B1 | Octocrylene-Free Sunscreen Agent Containing Diethylaminohydroxybenz Oylhexylbenzoate | BEIERSDORF |
16 Apr, 2020
|
LOREAL
(and 5 more)
| |
| EP2544668B1 | Therapeutic Agent Preparations For Delivery Into A Lumen Of The Intestinal Tract Using A Swallowable Drug Delivery Device | RANI THERAPEUTICS |
16 Apr, 2020
|
NOVO NORDISK
| |
| EP3225230B1 | Octocrylene-Free Sunscreen Agent Comprising Diethylhexylbutamidotriazone | BEIERSDORF |
16 Apr, 2020
|
SCHIWECK WEINZIERL KOCH PATENTANWLTE PARTNERSCHAFT MBB
(and 5 more)
| |
| EP3312196B1 | Antibodies Against Cd38 For Treatment Of Multiple Myeloma | GENMAB AS |
16 Apr, 2020
(Expiration: Mar, 2026)
|
SECERNA
| |
| EP2563508B1 | Delivery Particle | PROCTER AND GAMBLE CO |
09 Apr, 2020
(Expiration: May, 2030)
|
HENKEL
| |
| EP2714071B1 | Individualized Vaccines For Cancer | BIONTECH |
09 Apr, 2020
|
IPRIME RENTSCH KAELIN
(and 2 more)
| |
| EP3248600B8 | Combinations And Modes Of Administration Of Therapeutic Agents And Combination Therapy | ABRAXIS BIOSCIENCE LLC |
09 Apr, 2020
(Expiration: Feb, 2026)
|
TEVA PHARMACEUTICAL INDUSTRIES
(and 1 more)
| |
| EP1797886B1 | Immune Stimulation Using Chemically Modified Rna | CUREVAC AG |
09 Apr, 2020
(Expiration: Jul, 2023)
|
WEINZIERL
(and 1 more)
| |
| EP3002298B1 | Anti-Factor Xi Monoclonal Antibodies And Methods Of Use Thereof | OREGON HEALTH SCIENCE UNIVERSITY |
08 Apr, 2020
(Expiration: Nov, 2028)
|
MERCK SHARP & DOHME
| |
| EP2694834B2 | Keratin-Based Hair Straightening Formulations, Methods And Systems | BAUM MARC MICHAEL |
07 Apr, 2020
|
HENKEL
| |
| EP2866776B1 | Two Coat Process For Dyeing Keratin Fibres | LOREAL |
07 Apr, 2020
|
HENKEL
(and 1 more)
| |
| EP2861087B1 | Metabolic Imprinting Effects Of Nutrition With Large Lipid Globules Comprising Milk Fat And Vegetable Fat | NUTRICIA |
06 Apr, 2020
|
SOCIT DES PRODUITS NESTL
(and 1 more)
| |
| EP3079474B1 | Antiparasitic Use Of Isoxazoline Compounds | INTERVET |
03 Apr, 2020
|
CEVA SANTE ANIMALE
(and 1 more)
| |
| EP3076939B1 | Agent For Oxidatively Dyeing Hair Containing Specific Combinations Of Developers And Couplers | HENKEL |
03 Apr, 2020
|
KAO GERMANY
(and 1 more)
| |
| EP2104490B1 | Micronised Particles Of Low-Dosage Strength Active Agents For Powder Formulations For Inhalation | CHIESI FARMACEUTICI |
03 Apr, 2020
|
MAIWALD PATENTANWALTS UND RECHTSANWALTSGESELLSCHAFT
| |
| EP3024448B8 | Compositions And Methods Using P-Anisaldehyde | SOCIT DES PRODUITS NESTL |
03 Apr, 2020
|
NUTRICIA
| |
| EP2907497B1 | Cosmetic Emulsifier Combination | BEIERSDORF |
02 Apr, 2020
|
BASF
| |
| EP3270871B1 | Cosmetic Compositions Comprising A Talc Particulate | IMERTECH SAS |
02 Apr, 2020
(Expiration: Mar, 2036)
|
IMI FABI
| |
| EP2919823B1 | Antimicrobial Articles Produced By Additive Manufacturing | ORTHOPAEDIC INNOVATION CENTRE |
01 Apr, 2020
|
WUESTHOFF & WUESTHOFF PATENTANWLTE PARTG MBB
| |
| EP2651958B2 | Glycoside Blends | CARGILL INCORPORATED |
31 Mar, 2020
|
J A KEMP
| |
| EP3076983B1 | Ionic Aqueous Compositions | GEROLYMATOS |
30 Mar, 2020
|
MARINOMED BIOTECH
(and 1 more)
| |
| EP3173092B1 | Rna Containing Composition For Treatment Of Tumor Diseases | CUREVAC |
26 Mar, 2020
|
FRIEDRICH
(and 4 more)
| |
| EP2873733B2 | Vectors For Transforming Mycoplasma Hyopneumoniae, Transformed M. Hyopneumoniae Strains, And Use Thereof | HIPRA SCIENTIFIC SLU |
26 Mar, 2020
|
INTERVET
| |
| EP2884979B1 | Combination Therapies For Melanoma Comprising Administering Cobimetinib And Vemurafinib | F HOFFMANN LA ROCHE |
24 Mar, 2020
(Expiration: Aug, 2033)
|
SANDOZ
| |
| EP2380581B1 | Muscle-Building Agent | MEGMILK SNOW BRAND CO LTD |
23 Mar, 2020
(Expiration: Dec, 2029)
|
FRESENIUS KABI DEUTSCHLAND
(and 2 more)
| |
| EP3068437B2 | Sprayable Topical Carrier And Composition Comprising Phosphatidylcholine | LIPIDOR |
19 Mar, 2020
|
BEIERSDORF
| |
| EP2687213B1 | Solid Forms Comprising (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione, Compositions Thereof, And Uses Thereof | CELGENE CORP |
19 Mar, 2020
(Expiration: Mar, 2028)
|
GENERICS UK
| |
| EP2911684B1 | Il-15R Alpha Forms, Cells Expressing Il-15R Alpha Forms, And Therapeutic Uses Of Il-15R Alpha And Il-15/Il-15R Alpha Complexes | NOVARTIS |
19 Mar, 2020
(Expiration: Oct, 2033)
|
GRAF VON STOSCH
| |
| EP2968221B1 | Pharmaceutical Composition Of S-Ketamine Hydrochloride | JANSSEN PHARMACEUTICA NV |
18 Mar, 2020
(Expiration: Mar, 2034)
|
ASPIRE PHARMA
(and 1 more)
| |
| EP3153179B1 | Optimised Injection Formulation For Mrna | CUREVAC |
18 Mar, 2020
|
ETHERNA IMMUNOTHERAPIES
(and 1 more)
| |
| EP3233030B1 | Composition In The Form Of O/W Emulsion | LOREAL SA |
17 Mar, 2020
(Expiration: Dec, 2035)
|
HENKEL
(and 1 more)
| |
| EP2358642B2 | Method For Reducing The Concentration Of Amines And Salts Thereof | FROXIMUN |
16 Mar, 2020
|
GLOCK HEALTH
| |
| EP3138916B1 | Immunogenic Composition | GLAXOSMITHKLINE BIOLOGICALS SA |
16 Mar, 2020
(Expiration: May, 2032)
|
VALNEVA AUSTRIA
| |
| EP2374452B1 | Nutrient Composition | AJINOMOTO |
13 Mar, 2020
|
FRESENIUS KABI DEUTSCHLAND
| |
| EP2841054B2 | Injectable Preparation | OTSUKA PHARMACEUTICAL |
13 Mar, 2020
|
MAIWALD PATENT UND RECHTSANWALTSGESELLSCHAFT
| |
| EP2488033B1 | Combination | NOVARTIS |
12 Mar, 2020
(Expiration: Oct, 2030)
|
GENERICS UK
(and 1 more)
| |
| EP3034073B1 | Use Of A Composition Comprising Formoterol And Beclometasone Dipropionate For The Prevention And/Or Treatment Of An Exacerbation Of Asthma | CHIESI FARMACEUTICI |
12 Mar, 2020
|
LUPIN HEALTHCARE UK
(and 2 more)
| |
| EP2836196B1 | Preparation For Topical Application To Mucosa Containing Polyhexanide As Active Ingredient | MERZ PHARMA GMBH AND CO KGAA |
12 Mar, 2020
(Expiration: Apr, 2033)
|
MARIA CLEMENTINE MARTIN KLOSTERFRAU VERTRIEBSGESELLSCHAFT
| |
| EP2640413B1 | A Process For Reduction And/Or Removal Of Fxi And Fxia From Solutions Containing Said Coagulation Factors | OCTAPHARMA |
12 Mar, 2020
|
STRAWMAN
| |
| EP1687308B1 | Crystalline Forms Of (6R) -L-Erythro-Tetrahydrobiopterin Dihydrochloride | MERCK & CIE |
11 Mar, 2020
|
LEDERER & KELLER PATENTANWLTE PARTNERSCHAFT MBB
| |
| EP3179989B1 | Silicone-Containing Acrylic Polymers For Transdermal Drug Delivery Compositions | NOVEN PHARMACEUTICALS INC |
11 Mar, 2020
(Expiration: Jul, 2035)
|
LTS LOHMANN THERAPIE SYSTEME
| |
| EP2863876B1 | Hair Colorant Compositions Comprising 2-Methoxymethyl-1,4-Diaminobenzene, Methods, And Kits | NOXELL CORP |
10 Mar, 2020
(Expiration: Jun, 2033)
|
HENKEL
| |
| EP2787965B1 | Composition Based On Red Henna Powder And Oil(S), And Hair Dyeing Process Using This Composition | LOREAL SA |
09 Mar, 2020
(Expiration: Dec, 2032)
|
HENKEL
(and 1 more)
| |
| EP2678011B1 | Antitumoral Combination Comprising Cabazitaxel And Cisplatin | AVENTIS PHARMA SA |
05 Mar, 2020
(Expiration: Feb, 2032)
|
GENERICS UK
| |
| EP2877201B1 | A Liquid Formulation Of Long-Acting Insulin And Insulinotropic Peptide | HANMI PHARM |
05 Mar, 2020
|
JAMES POOLE
| |
| EP3024479B2 | High Potency Pancreatin Pharmaceutical Compositions | ALLERGAN PHARMACEUTICALS |
05 Mar, 2020
|
MATHYS & SQUIRE
| |
| EP2780022B2 | Pharmaceutical Preparations Of Human Rpe Cells And Uses Thereof | ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE |
05 Mar, 2020
|
STRAWMAN
| |
| EP2223688B1 | (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions Thereof | CELGENE CORP |
02 Mar, 2020
(Expiration: Mar, 2023)
|
GALENICUM HEALTH SLU
(and 4 more)
| |
| EP2720757B1 | Preparations That Conform To The Principles Of Organic Cosmetics | BEIERSDORF |
28 Feb, 2020
|
FA SCHWANHUER INDUSTRIE HOLDING
| |
| EP2812443B1 | Cd47 Antibodies And Methods Of Use Thereof | INHIBRX |
28 Feb, 2020
|
FORTY SEVEN
| |
| EP2448551B1 | Ester Mixtures And Compositions Comprising Such Ester Mixtures | COGNIS IP MANAGEMENT GMBH |
28 Feb, 2020
(Expiration: Jun, 2030)
|
KADOR & PARTNER PARTG MBB
| |
| EP2879656B1 | Dye Composition In Cream Form Comprising At Least One Oil And Little Or No Solid Fatty Alcohol, Dyeing Process And Suitable Device | LOREAL |
28 Feb, 2020
|
KAO GERMANY
| |
| EP3019180B1 | Beta-Casein A2 And Reducing Or Preventing Symptoms Of Lactose Intolerance | THE A MILK |
28 Feb, 2020
|
NUTRICIA
| |
| EP3116534B1 | Compositions Of Human Prothrombin And Activated Factor X For Improving Hemostasis In The Treatment Of Bleeding Disorders | BAXALTA GMBH |
28 Feb, 2020
(Expiration: Mar, 2035)
|
OCTAPHARMA
| |
| EP2658391B1 | Non-Medical Increase Or Maintenance Of Body Weight Of A Mammal | NUTRICIA |
25 Feb, 2020
|
SOCIT DES PRODUITS NESTL
| |
| EP2687103B1 | Aqueous Transparent Oil-In-Water Emulsion Comprising An Emulsified Carotenoid | BASF |
24 Feb, 2020
|
DSM NUTRITIONAL PRODUCTS
| |
| EP3351246B8 | Rapamycin Derivative For The Treatment Of A Solid Tumor Associated With Deregulated Angiogenesis | NOVARTIS PHARMA AG |
21 Feb, 2020
(Expiration: Feb, 2022)
|
GENERICS UK
(and 9 more)
| |
| EP3143998B1 | An Inhalable Medicament Comprising Tiotropium | TEVA BRANDED PHARMACEUTICAL PRODUCTS R & D |
21 Feb, 2020
|
M INNOVATIVE PROPERTIES
| |
| EP2787078B1 | Antigen-Binding Molecule Having Regulated Conjugation Between Heavy-Chain And Light-Chain | CHUGAI PHARMACEUTICAL CO LTD |
21 Feb, 2020
(Expiration: Oct, 2032)
|
STRAWMAN
| |
| EP3212296B1 | Anhydrous Antiperspirant Aerosol Compositions | UNILEVER |
21 Feb, 2020
|
THE PROCTER & GAMBLE
| |
| EP3176240B2 | Process For Preparing Alcohol Ether Sulfates | CHEVRON ORONITE |
20 Feb, 2020
|
SASOL PERFORMANCE CHEMICALS
| |
| EP2819699B1 | Controlled Release Compositions And Their Methods Of Use | ELANCO NEW ZEALAND |
19 Feb, 2020
|
BOEHRINGER INGELHEIM ANIMAL HEALTH USA
| |
| EP2289531B1 | Medicaments For Increasing Endogenous Erythropoietine (Epo) | FIBROGEN |
19 Feb, 2020
|
GLAXOSMITHKLINE UK
(and 1 more)
| |
| EP2892528B1 | Pharmaceutical Compositions Comprising Flurbiprofen | RECKITT BENCKISER HEALTHCARE |
17 Feb, 2020
|
TER MEER STEINMEISTER & PARTNER PATENTANWLTE MBB
| |
| EP2400950B1 | Pharmaceutical Formulations Comprising 4-{(1R)-2- [(6-{2-[(2,6-Dichlorobenzyl)Oxy] Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2- (Hydroxymethyl)Phenol | GLAXO GROUP |
14 Feb, 2020
|
ARVEN ILAC SANAYI VE TICARET
(and 7 more)
| |
| EP2825558B1 | Combination Therapy For The Treatment Of Ovarian Cancer | F HOFFMANN LA ROCHE AG |
14 Feb, 2020
(Expiration: Mar, 2033)
|
MABXIENCE RESEARCH
(and 8 more)
| |
| EP3065777B2 | Methods Of Use For Il-22 In The Treatment Of Gastrointestinal Graft Vs. Host Disease | MEMORIAL SLOAN KETTERING CANCER CENTER |
14 Feb, 2020
|
STRAWMAN
| |
| EP3003485B1 | Beta-Casein A2 And Prevention Of Inflammation Of The Bowel | A2 MILK CO LTD |
13 Feb, 2020
(Expiration: May, 2034)
|
FRESENIUS KABI DEUTSCHLAND
(and 1 more)
| |
| EP2766040B1 | Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor Pertuzumab | F HOFFMANN LA ROCHE AG |
13 Feb, 2020
(Expiration: Oct, 2032)
|
KNIG SZYNKA TILMANN VON RENESSE
(and 8 more)
| |
| EP2111416B2 | Iron-Hydrocarbon Complex Compounds | VIFOR |
13 Feb, 2020
|
NUTRICIA
| |
| EP3016666B1 | A Marine Oil Formulation Comprising Reservatrol Or Derivatives Thereof For Use In Treating, Delaying And/Or Preventing Alzheimer'S Desease | SMARTFISH AS |
13 Feb, 2020
(Expiration: Jun, 2034)
|
NUTRICIA
| |
| EP2865376B2 | Adhesive Preparation Composition Obtained By Blending Drug, Organic Solvent, Lipophilic Ointment Base, And Powder | MEDRX |
11 Feb, 2020
|
HOFFMAN EITLE PATENT UND RECHTSANWLTE PARTNERSCHAFTSGESELLSCHAFT MBB
| |
| EP1294379B1 | A New Use For Deferiprone | APOTEX INC |
11 Feb, 2020
(Expiration: Jun, 2021)
|
LIPOMED
| |
| EP2324834B1 | Methods Of Increasing Endogenous Erythropoietin (Epo) | FIBROGEN INC |
10 Feb, 2020
(Expiration: Dec, 2022)
|
AKEBIA THERAPEUTICS
| |
| EP2506825B2 | Hatching Fluid Enzymes And Uses Thereof | AQUA BIO TECHNOLOGY ASA |
10 Feb, 2020
|
REGENICS
| |
| EP2347762B1 | Exendin For Treating Diabetes And Reducing Body Weight | AMYLIN PHARMACEUTICALS LLC |
07 Feb, 2020
(Expiration: Aug, 2026)
|
GENERICS UK
(and 1 more)
| |
| EP3068396B1 | Rapidly Disintegrating Formulations And Methods Of Use | IMPAX LABORATORIES LLC |
07 Feb, 2020
(Expiration: Nov, 2034)
|
LEDERER & KELLER PATENTANWLTE PARTNERSCHAFT MBB
| |
| EP2533751B1 | Composition For Cleaning Teeth Comprising Natural Glass And Related Methods | IMERYS FILTRATION MINERALS |
07 Feb, 2020
|
NORDISK PERLITE APS
| |
| EP2790706B1 | Phytoecdysones For Use In Improving The Muscle Quality Of Obese And/Or Sarcopenic Mammals | BIOPHYTIS |
07 Feb, 2020
|
VIDON BREVETS & STRATGIE
| |
| EP2897588B1 | An Inhalable Medicament | TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D |
06 Feb, 2020
|
CHIESI FARMACEUTICI
| |
| EP3344607B1 | Solid State Forms Of Selexipag | TEVA PHARMACEUTICALS |
06 Feb, 2020
|
CHIESI FARMACEUTICI
(and 1 more)
| |
| EP3284520B1 | Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory Activity | VIIV HEALTHCARE |
04 Feb, 2020
|
GILEAD SCIENCES
| |
| EP2912074B2 | Dermal Injectable Sterile Composition | TEOXANE |
03 Feb, 2020
|
ALLERGAN
| |
| EP2626058B1 | Dental Canaliculi Sealing Agent And Method For Producing The Same | KURARAY NORITAKE DENTAL |
03 Feb, 2020
|
OMYA
| |
| EP3292873B1 | Combination Of Vaccination And Inhibition Of The Pd-1 Pathway | CUREVAC |
03 Feb, 2020
|
PFIZER
(and 5 more)
| |
| EP1991688B1 | Biodegradable Compositions Comprising Renewably-Based, Biodegradable 1.3-Propanediol | PRIMIENT COVATION |
31 Jan, 2020
|
DSM NUTRITIONAL PRODUCTS
| |
| EP2451482B1 | Combination Therapy For The Treatment Of Diabetes | JANSSEN PHARMACEUTICA NV |
31 Jan, 2020
(Expiration: Jul, 2030)
|
GENERICS UK
(and 1 more)
| |
| EP3043768B2 | Method For The Treatment Of Hair From A Composition Comprising An Organic Monoacid And A Cellulosic Polymer | LOREAL |
31 Jan, 2020
|
KAO GERMANY
(and 1 more)
| |
| EP2649982B1 | Hair Bleaching Composition And Method For Producing Same | ARTEC CHEMICAL CO LTD |
31 Jan, 2020
(Expiration: Mar, 2033)
|
KAO GERMANY
(and 1 more)
| |
| EP2344141B1 | Compositions Comrrising Amlodipine And Bisoprolol | EGYT GYOGYSZERVEGYESZETI GYAR |
31 Jan, 2020
(Expiration: Sep, 2029)
|
KRKA
| |
| EP2742803B1 | Isothiazolinone Biocides Enhanced By Metal Ions | ARCH CHEMICALS |
31 Jan, 2020
|
PPG INDUSTRIES
| |
| EP2968549B2 | Methods Of Cell Culture | MOMENTA PHARMACEUTICALS |
31 Jan, 2020
|
REGENERON PHARMACEUTICALS
(and 1 more)
| |
| EP3166572B1 | Anti-Calculus Oral Compositions | PROCTER AND GAMBLE CO |
31 Jan, 2020
(Expiration: Jul, 2034)
|
TRSCH
| |
| EP1317918B1 | Cosmetic Sunscreen Compositions Based On Synergistic Filter Mixture And Their Use | LOREAL SA |
30 Jan, 2020
(Expiration: Nov, 2022)
|
STADA ARZNEIMITTEL
| |
| EP3177323B2 | Photo-Controlled Removal Of Targets In Vitro And In Vivo | THE UNITED STATES OF AMERICA REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES |
30 Jan, 2020
|
STRAWMAN
| |
| EP3129485B2 | Crispr/Cas-Related Methods And Compositions For Treating Cystic Fibrosis | EDITAS MEDICINE |
28 Jan, 2020
|
JAMES POOLE
| |
| EP2953621B1 | Topical Antifungal Composition For Treating Onychomycosis | POLICHEM |
28 Jan, 2020
|
WILSON GUNN
| |
| EP3373914B2 | Storage Stable Composition Comprising Rifaximin Alpha | SANDOZ |
24 Jan, 2020
|
ALFASIGMA
| |
| EP2658514B2 | Cleansing Composition Especially For Artificially Coloured Hair | KAO GERMANY |
24 Jan, 2020
|
HENKEL
| |
| EP2494983B1 | Stable Formulations Of Glp-1 | NOVO NORDISK AS |
24 Jan, 2020
(Expiration: Nov, 2025)
|
HOFFMANN EITLE
(and 1 more)
| |
| EP2872533B1 | Methods Of Assessing The Suitability Of Transduced T Cells For Administration | UNIVERSITY OF PENNSYLVANIA PENN |
24 Jan, 2020
(Expiration: Jul, 2033)
|
PATENT BOUTIQUE
(and 1 more)
| |
| EP3209387B1 | Chitosan-Containing Antiperspirant Cosmetic Agents Which Are Free Of Halides And/Or Hydroxy Halides Of Aluminum And/Or Zirconium | HENKEL AG AND CO KGAA |
24 Jan, 2020
(Expiration: Sep, 2035)
|
THE PROCTER & GAMBLE
| |
| EP3234025B1 | Red-Coloured Decorative Pigments With High Chroma And High Brilliancy, Method For Their Production And Use Of Same | ECKART |
23 Jan, 2020
|
BASF COLORS & EFFECTS
| |
| EP2800476B1 | Method Of Feeding | DUPONT NUTRITION BIOSCIENCES APS |
23 Jan, 2020
|
NOVOZYMES
| |
| EP3049056B2 | Antifungal Topical Composition And Methods Of Treatment | BLUEBERRY THERAPEUTICS |
23 Jan, 2020
|
WILSON GUNN
| |
| EP3494997B1 | Inducible Dna Binding Proteins And Genome Perturbation Tools And Applications Thereof | THE BROAD INSTITUTE |
21 Jan, 2020
|
GRUND
(and 3 more)
| |
| EP3273934B1 | Method For Cosmetic Treatment Of The Hair | LOREAL |
20 Jan, 2020
|
HENKEL
(and 1 more)
| |
| EP3395339B8 | Rapid Dissolution Formulation Of A Cinacalcet Hcl | AMGEN INC |
17 Jan, 2020
(Expiration: Sep, 2024)
|
AECHTER
(and 10 more)
| |
| EP3140008B1 | Rapid-Acting Insulin Compositions | ELI LILLY |
17 Jan, 2020
|
COOKE
| |
| EP3056515B1 | Methods For Manipulating Phagocytosis Mediated By Cd47 | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY |
17 Jan, 2020
|
GENMAB
(and 3 more)
| |
| EP3260117B8 | Rapid Dissolution Formulation Of A Calcium Receptor-Active Compound | AMGEN INC |
17 Jan, 2020
(Expiration: Sep, 2024)
|
HGF
(and 6 more)
| |
| EP3056514B1 | Methods For Manipulating Phagocytosis Mediated By Cd47 | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY |
17 Jan, 2020
|
MATHYS & SQUIRE
(and 3 more)
| |
| EP3395340B8 | Rapid Dissolution Formulation Of Cinacalcet Hcl | AMGEN INC |
16 Jan, 2020
(Expiration: Sep, 2024)
|
GLENMARK PHARMACEUTICALS EUROPE
(and 8 more)
| |
| EP2190434B1 | Purin Derivatives For Use In The Treatment Of Fab-Related Diseases | BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
16 Jan, 2020
(Expiration: Aug, 2028)
|
HEXAL
| |
| EP2957280B1 | Solid Pharmaceutical Composition Of Cytisine And Process For Preparation Thereof | AFLOFARM FARMACJA POLSKA SP Z OO |
16 Jan, 2020
|
SOPHARMA AD
(and 1 more)
| |
| EP3318248B1 | Delivery Of Mrna For The Augmentation Of Proteins And Enzymes In Human Genetic Diseases | TRANSLATE BIO |
10 Jan, 2020
|
BRADY
(and 1 more)
| |
| EP3186281B1 | Combination Therapy With A Hyaluronan-Degrading Enzyme And An Immune Checkpoint Inhibitor | HALOZYME INC |
10 Jan, 2020
(Expiration: Aug, 2035)
|
J A KEMP
| |
| EP2173324B1 | Hyaluronic Acid Injectable Gel For Treating Joint Degeneration | APTISSEN |
10 Jan, 2020
|
LABORATOIRES VIVACY
| |
| EP2322517B1 | Methods Of Chemical Synthesis And Purification Of Diaminophenothiazinium Compounds Including Methylthioninium Chloride (Mtc) | WISTA LABORATORIES |
10 Jan, 2020
|
PROVEPHARM LIFE SOLUTIONSPROVEPHARM
(and 1 more)
| |
| EP2892558B1 | Vista Modulators For Diagnosis And Treatment Of Cancer | THE TRUSTEES OF DARTMOUTH COLLEGE |
10 Jan, 2020
|
REGIMBEAU
| |
| EP2962686B1 | Dosage Form Containing Oxycodone And Naloxone | EURO CELTIQUE SA |
09 Jan, 2020
(Expiration: Feb, 2026)
|
ARISTO PHARMA
(and 6 more)
| |
| EP2460820B8 | Pcv2 Immunogenic Compositions And Methods Of Producing Such Compositions | BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC |
09 Jan, 2020
(Expiration: Dec, 2025)
|
CEVA SANTE ANIMALE
(and 2 more)
| |
| EP3351240B1 | Formulations Of 4-Amino-2-(2,6-Dioxopiperidine-3-Yl)Isoindoline-1,3-Dione | CELGENE |
09 Jan, 2020
|
GENERICS UK
(and 3 more)
| |
| EP3107556B1 | Compositions For Preventing And/Or Treating Pathological Conditions Associated With Alpha-Glucosidase | UNIVERSITE DE LA ROCHELLE |
07 Jan, 2020
(Expiration: Feb, 2035)
|
ARLA FOODS AMBA
| |
| EP3093009B1 | Octocrylene-Free Sunscreen Agent With Diethylaminohydroxybenzoylhexylbenzoate | BEIERSDORF AG |
06 Jan, 2020
(Expiration: May, 2036)
|
DALLI WERKE
(and 4 more)
| |
| EP2734185B1 | Dyeing Process Using A Natural Dye On Keratin Fibres That Have Undergone Permanent Reshaping | LOREAL SA |
06 Jan, 2020
(Expiration: Jul, 2032)
|
KAO GERMANY
| |
| EP2842569B1 | One Dose Vaccination With Mycoplasma Hyopneumoniae | ZOETIS SERVICES LLC |
03 Jan, 2020
(Expiration: Jun, 2022)
|
BOEHRINGER INGELHEIM ANIMAL HEALTH USA
| |
| EP2859075B1 | Biosolubilizer | GIVAUDAN SA |
03 Jan, 2020
(Expiration: May, 2033)
|
EVONIK OPERATIONS
(and 1 more)
| |
| EP2970493B1 | Methods For Achieving Therapeutically Effective Doses Of Anti-Cd47 Agents | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY |
03 Jan, 2020
|
GENMAB
(and 1 more)
| |
| EP3401400B1 | Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
03 Jan, 2020
|
GREAVES BREWSTER
(and 3 more)
| |
| EP2747748B1 | Non-Aqueous Composition For Hair | KAO GERMANY |
03 Jan, 2020
|
HENKEL
| |
| EP2819640B1 | Use Of Powdered Cellulose In Cosmetic Applications | EVONIK OPERATIONS |
03 Jan, 2020
|
MAYR KOTSCH PATENTANWALT RECHTSANWLTIN PARTNERSCHAFTSGESELLSCHAFT MBB
| |
| EP2113567B1 | Microrna Target Site Blocking Oligos And Uses Thereof | QIAGEN |
03 Jan, 2020
|
RANGER BIOTECHNOLOGIES
| |
| EP2964203B1 | Novel Esterified Cellulose Ethers Of Very High Molecular Weight | DOW |
03 Jan, 2020
|
SHIN ETSU CHEMICAL
| |
| EP2723774B1 | Method For Manufacturing Hydroxyethyl Starch Derivatives | SERUMWERK BERNBURG |
03 Jan, 2020
|
STRAWMAN
| |
| EP3165220B1 | Pharmaceutical Composition Containing An Anti-Nucleating Agent | MERCK SHARP & DOHME |
03 Jan, 2020
|
TER MEER STEINMEISTER & PARTNER PATENTANWLTE MBB
(and 1 more)
| |
| EP3111954B1 | Methods Of Treating Ankylosing Spondylitis Or Psoriatic Arthritis Using Anti-Il-17 Antibodies | NOVARTIS AG |
02 Jan, 2020
(Expiration: Nov, 2031)
|
DR REDDYS LABORATORIES
(and 2 more)
|